BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

459 related articles for article (PubMed ID: 30472151)

  • 1. Purinergic signaling in Alzheimer's disease.
    Erb L; Woods LT; Khalafalla MG; Weisman GA
    Brain Res Bull; 2019 Sep; 151():25-37. PubMed ID: 30472151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purinergic receptors as potential therapeutic targets in Alzheimer's disease.
    Woods LT; Ajit D; Camden JM; Erb L; Weisman GA
    Neuropharmacology; 2016 May; 104():169-79. PubMed ID: 26519903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An introduction to the roles of purinergic signalling in neurodegeneration, neuroprotection and neuroregeneration.
    Burnstock G
    Neuropharmacology; 2016 May; 104():4-17. PubMed ID: 26056033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purinergic signaling in the retina: From development to disease.
    Ventura ALM; Dos Santos-Rodrigues A; Mitchell CH; Faillace MP
    Brain Res Bull; 2019 Sep; 151():92-108. PubMed ID: 30458250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of purinergic receptors in the Alzheimer's disease.
    Cieślak M; Wojtczak A
    Purinergic Signal; 2018 Dec; 14(4):331-344. PubMed ID: 30362042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purinergic receptors in multiple sclerosis pathogenesis.
    Domercq M; Zabala A; Matute C
    Brain Res Bull; 2019 Sep; 151():38-45. PubMed ID: 30500565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Therapeutic Potential of Purinergic Receptors in Alzheimer's Disease and Promising Therapeutic Modulators.
    Pan L; Ma Y; Li Y; Wu H; Huang R; Cai Z; Wu X
    Mini Rev Med Chem; 2021; 21(11):1288-1302. PubMed ID: 33302833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Introduction to Purinergic Signaling.
    Burnstock G
    Methods Mol Biol; 2020; 2041():1-15. PubMed ID: 31646477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The P2Y/P2X divide: How it began.
    Kennedy C
    Biochem Pharmacol; 2021 May; 187():114408. PubMed ID: 33444568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular mechanisms of tissue fibrosis. 6. Purinergic signaling and response in fibroblasts and tissue fibrosis.
    Lu D; Insel PA
    Am J Physiol Cell Physiol; 2014 May; 306(9):C779-88. PubMed ID: 24352335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alzheimer and Purinergic Signaling: Just a Matter of Inflammation?
    Merighi S; Poloni TE; Terrazzan A; Moretti E; Gessi S; Ferrari D
    Cells; 2021 May; 10(5):. PubMed ID: 34065393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medicinal chemistry of adenosine, P2Y and P2X receptors.
    Jacobson KA; Müller CE
    Neuropharmacology; 2016 May; 104():31-49. PubMed ID: 26686393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purinergic signaling negatively regulates activity of an olfactory receptor in an odorant-dependent manner.
    Yu Y; Zhang C
    Neuroscience; 2014 Sep; 275():89-101. PubMed ID: 24928349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ATP- and adenosine-mediated signaling in the central nervous system: purinergic receptor complex: generating adenine nucleotide-sensitive adenosine receptors.
    Yoshioka K; Nakata H
    J Pharmacol Sci; 2004 Feb; 94(2):88-94. PubMed ID: 14978342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purinergic receptors in embryonic and adult neurogenesis.
    Oliveira Á; Illes P; Ulrich H
    Neuropharmacology; 2016 May; 104():272-81. PubMed ID: 26456352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of mediators of purinergic signaling in human liver cell lines.
    Goree JR; Lavoie EG; Fausther M; Dranoff JA
    Purinergic Signal; 2014 Dec; 10(4):631-8. PubMed ID: 25194703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P2Y receptors in Alzheimer's disease.
    Erb L; Cao C; Ajit D; Weisman GA
    Biol Cell; 2015 Jan; 107(1):1-21. PubMed ID: 25179475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purinergic P2X, P2Y and adenosine receptors differentially modulate hippocampal gamma oscillations.
    Schulz SB; Klaft ZJ; Rösler AR; Heinemann U; Gerevich Z
    Neuropharmacology; 2012 Feb; 62(2):914-24. PubMed ID: 22001427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purinergic signaling in infectious diseases of the central nervous system.
    Alves VS; Leite-Aguiar R; Silva JPD; Coutinho-Silva R; Savio LEB
    Brain Behav Immun; 2020 Oct; 89():480-490. PubMed ID: 32717399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Adjustment of intercellular communication via extracellular ATP in the nervous system].
    Baranowska-Bosiacka I
    Ann Acad Med Stetin; 2013; ():119-23. PubMed ID: 24669428
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 23.